- Filed
- May 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 9, 2025 | 139.21M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $90.08M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $97.13M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $5.66M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $5.34M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $32.82M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $30.88M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $204.91M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $231.94M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $302.15M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $281.74M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 70.32M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $97K |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$7.29M |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | −$57.28M |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2023 | −$34.36M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.34 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.34 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $3.71M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $3.66M |
| Net Income restated | Q1 2025 · Mar 31, 2024 | −$24.02M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$7.37M |